CCM
Cinctive Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $599K | Buy |
+4,766
| New | +$599K | 0.03% | 291 |
|
|
2025
Q1 | – | Sell |
-16,366
| Closed | -$2.23M | – | 399 |
|
|
2024
Q4 | $2.23M | Buy |
+16,366
| New | +$2.23M | 0.11% | 200 |
|
|
2024
Q2 | – | Sell |
-9,983
| Closed | -$1.38M | – | 460 |
|
|
2024
Q1 | $1.38M | Buy |
+9,983
| New | +$1.38M | 0.06% | 241 |
|
|
2022
Q1 | – | Sell |
-67,825
| Closed | -$5.78M | – | 547 |
|
|
2021
Q4 | $5.78M | Sell |
67,825
-35,948
| -35% | -$3.06M | 0.25% | 121 |
|
|
2021
Q3 | $9.95M | Buy |
103,773
+26,734
| +35% | +$2.56M | 0.49% | 39 |
|
|
2021
Q2 | $7.5M | Buy |
77,039
+28,248
| +58% | +$2.75M | 0.35% | 71 |
|
|
2021
Q1 | $4.75M | Buy |
+48,791
| New | +$4.75M | 0.29% | 135 |
|
|
2020
Q3 | – | Sell |
-33,393
| Closed | -$4.07M | – | 331 |
|
|
2020
Q2 | $4.07M | Sell |
33,393
-1,289
| -4% | -$157K | 0.47% | 73 |
|
|
2020
Q1 | $3M | Buy |
+34,682
| New | +$3M | 0.67% | 45 |
|